Skip to main content

Table 1 Protein identification using MALDI-TOF MS/MS

From: Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis

No. gi| Protein name
A01 251,837,060 Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
A02 110,590,599 Chain A, Apo-Human Serum Transferrin (Glycosylated)
A04 78,174,390 HP protein
A05 220,702,427 Chain B, Crystal Structure Of Bbetad432a Variant Fibrinogen Fragment D With The Peptide Ligand Gly-His-Arg-Pro-Amide
A06 7,770,217 PRO2675
A07 49,258,810 Chain A, Human Serum Transferrin, N-Lobe Bound With Oxalate
A09 158,254,550 unnamed protein product
A10 193,787,502 unnamed protein product
A12 32,891,795 clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J)
A13 86,439,006 immunoglobulin lambda light chain
A17 7,770,173 PRO2222 (RBP4)
A18 212,374,952 Chain A, Crystal Structure Of Transthyretin Variant V20 s
B02 2,781,209 Chain C, Crystal Structure Of Fibrinogen Fragment D
B10 3,413,516 Hakata antigen (H-ficolin)
B11 119,626,073 albumin, isoform CRA_j
B12 576,259 Chain A, The Structure Of Pentameric Human Serum Amyloid P Component
B13 149,673,887 immunoglobulin light chain
B14 170,684,606 immunoglobulin kappa 1 light chain